Alcohol-associated hepatitis induces hepatocyte senescence which is reduced following disease resolution
RNA-seq (gene expression) · human · 73 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 73 samples: 6 conditions, mostly with about 18 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescenceGut · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE270043_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1124900 and SRA study SRP513148. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 69 samples read as cases, 4 as controls.
How we read this: 6 replicated groups read from 73 sample titles; they account for 73 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8322272 VL-17A cells, control, rep 1 VL-17A cells, control,
- GSM8322273 VL-17A cells, control, rep 2 VL-17A cells, control,
- GSM8322274 VL-17A cells, control, rep 3 VL-17A cells, control,
- GSM8322275 VL-17A cells, control, rep 4 VL-17A cells, control,
- GSM8322276 VL-17A cells, ethanol treated, rep 1 VL-17A cells, ethanol t…
- GSM8322277 VL-17A cells, ethanol treated, rep 2 VL-17A cells, ethanol t…
- GSM8322278 VL-17A cells, ethanol treated, rep 3 VL-17A cells, ethanol t…
- GSM8322279 VL-17A cells, ethanol treated, rep 4 VL-17A cells, ethanol t…
- GSM8333203 Liver, Placebo, d0, patient 1019 Liver, Placebo, d0, pat…
- GSM8333204 Liver, Placebo, d28, patient 1019 Liver, Placebo, d28, pa…
- GSM8333205 Liver, Placebo, d0, patient 1023 Liver, Placebo, d0, pat…
- GSM8333206 Liver, Placebo, d28, patient 1023 Liver, Placebo, d28, pa…
- GSM8333207 Liver, Canakinumab, d0, patient 1029 Liver, Canakinumab, d0,…
- GSM8333208 Liver, Canakinumab, d28, patient 1029 Liver, Canakinumab, d28…
- GSM8333209 Liver, Canakinumab, d0, patient 106 Liver, Canakinumab, d0,…
- GSM8333210 Liver, Placebo, d0, patient 1077 Liver, Placebo, d0, pat…
- GSM8333211 Liver, Placebo, d28, patient 1077 Liver, Placebo, d28, pa…
- GSM8333212 Liver, Placebo, d0, patient 108 Liver, Placebo, d0, pat…
- GSM8333213 Liver, Placebo, d28, patient 108 Liver, Placebo, d28, pa…
- GSM8333214 Liver, Placebo, d0, patient 1143 Liver, Placebo, d0, pat…
- GSM8333215 Liver, Placebo, d28, patient 1143 Liver, Placebo, d28, pa…
- GSM8333216 Liver, Placebo, d0, patient 116 Liver, Placebo, d0, pat…
- GSM8333217 Liver, Placebo, d28, patient 116 Liver, Placebo, d28, pa…
- GSM8333218 Liver, Placebo, d0, patient 133 Liver, Placebo, d0, pat…
- GSM8333219 Liver, Placebo, d28, patient 133 Liver, Placebo, d28, pa…
- GSM8333220 Liver, Canakinumab, d0, patient 146 Liver, Canakinumab, d0,…
- GSM8333221 Liver, Canakinumab, d28, patient 146 Liver, Canakinumab, d28…
- GSM8333222 Liver, Placebo, d0, patient 156 Liver, Placebo, d0, pat…
- GSM8333223 Liver, Placebo, d28, patient 156 Liver, Placebo, d28, pa…
- GSM8333224 Liver, Placebo, d0, patient 1672 Liver, Placebo, d0, pat…
- GSM8333225 Liver, Placebo, d28, patient 1672 Liver, Placebo, d28, pa…
- GSM8333226 Liver, Canakinumab, d0, patient 179 Liver, Canakinumab, d0,…
- GSM8333227 Liver, Canakinumab, d28, patient 179 Liver, Canakinumab, d28…
- GSM8333228 Liver, Placebo, d0, patient 180 Liver, Placebo, d0, pat…
- GSM8333229 Liver, Placebo, d28, patient 180 Liver, Placebo, d28, pa…
- GSM8333230 Liver, Canakinumab, d0, patient 302 Liver, Canakinumab, d0,…
- GSM8333231 Liver, Canakinumab, d28, patient 302 Liver, Canakinumab, d28…
- GSM8333232 Liver, Placebo, d0, patient 303 Liver, Placebo, d0, pat…
- GSM8333233 Liver, Placebo, d28, patient 303 Liver, Placebo, d28, pa…
- GSM8333234 Liver, Placebo, d0, patient 307 Liver, Placebo, d0, pat…
+ 33 more — browse all 73 samples with per-sample file links →
- GSE295260 CDK4/6 inhibition induces a senescence-associated secretory phenotype via delayed NF-κB activation 40 samples shares senescence, induces
- GSE267788 Mechanical stretch induces senescence of alveolar epithelial cells and drives fibroblast activation by paracrine mechanisms 25 samples shares senescence, induces
- GSE331395 Replicative senescence in neural progenitors induces senescence-associated markers in midbrain organoids 24 samples shares senescence, induces
- GSE261187 Epigenetic priming induces cancer testis antigens and human endogenous retroviruses in glioma for enhanced T cell responses at single cell resolution (bulk RNA-Seq) 20 samples shares resolution, induces
- GSE255772 IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis [scRNA-seq] 13 samples shares alcohol-associated, hepatitis
- GSE282387 Temozolomide Induces Glioblastoma Dedifferentiation into Highly Malignant Stem-like Cells Through Senescence-Associated Reprogramming via HIF1α/HIF2α Regulation [RNA-seq] 12 samples shares senescence, induces
- GSE229736 Therapy Induced Senescence Promotes Immunogenicity in Acute Myeloid Leukemia through Reduced EZH2 Activity (RNA-seq AraC) 12 samples shares senescence, reduced
- GSE307329 Continuous NRTI-based antiretroviral therapy induces progressive senescence-like reprogramming of alveolar macrophages [ChIP-seq] 74 samples shares senescence, induces
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.